Bronchial inflammation in obstructive sleep apnea (OSA) patients Source: Eur Respir J 2003; 22: Suppl. 45, 466s Year: 2003
Exhaled breath markers in patients with obstructive sleep apnea (OSA): baseline assessment and the impact of treatment with nasal continuous positive airway pressure Source: Eur Respir J 2005; 26: Suppl. 49, 355s Year: 2005
Relationship between anthropometric parameters, sleep disordered breathing and airway inflammation (AI) in obese adults affected by obstructive sleep apnea (OSA) Source: Eur Respir J 2004; 24: Suppl. 48, 118s Year: 2004
Associations between obstructive sleep apnea syndrome (OSAS) and chronic airflow limitation in a general Norwegian population Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities Year: 2012
Increased rates of obstructive sleep apnea (OSA) in COVID-19-patients Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19 Year: 2021
Airway inflammation in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002
Impact of CPAP on asthmatic patients with obstructive sleep apnoea Source: Eur Respir J 2007; 29: 307-311 Year: 2007
Angiogenic factors in obstructive sleep apnea syndrome (OSA). Effects of nasal continuous positive airway pressure treatment (CPAP) Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008
Association between metabolic disturbances and inflammatory markers in obstructive sleep apnea (OSAS) patients Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Influence of nasal obstruction (NO) on obstructive sleep apnea (OSA) severity and continuous positive airway pressure (CPAP) adaptation problems Source: Annual Congress 2010 - The upper airway and oral appliances Year: 2010
Predictors of continuous positive airway pressure adherence in obstructive sleep apnea syndrome Source: International Congress 2017 – Inhalers and their use Year: 2017
The effect of theophylline and CPAP on cytokine release in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 216s Year: 2006
Local airway inflammation in obstructive sleep apnoea: the role of leptin Source: Eur Respir J 2006; 28: Suppl. 50, 645s Year: 2006
CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD Source: Eur Respir J 2010; 35: 132-137 Year: 2010
Dynamics of metabolic parameters after 3 days continuous positive airway pressure in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 413s Year: 2006
Bronchial reactivity in patients with obstructive sleep apnea syndrome treated with continuous positive airway pressure Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005
Endothelin-1 levels, respiratory drive and hypercapnic response in obese patients with or without obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control Year: 2010
Obesity, obstructive sleep apnea (OSA) and asthma Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009
Prediction of effective continuous positive airway pressure (CPAP) in obstructive sleep apnea syndrome (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 111s Year: 2005